HRP20020298B1 - Farmaceutske otopine levosimendana - Google Patents

Farmaceutske otopine levosimendana

Info

Publication number
HRP20020298B1
HRP20020298B1 HR20020298A HRP20020298A HRP20020298B1 HR P20020298 B1 HRP20020298 B1 HR P20020298B1 HR 20020298 A HR20020298 A HR 20020298A HR P20020298 A HRP20020298 A HR P20020298A HR P20020298 B1 HRP20020298 B1 HR P20020298B1
Authority
HR
Croatia
Prior art keywords
levosimendan
pharmaceutical solutions
less
solution
infusion
Prior art date
Application number
HR20020298A
Other languages
English (en)
Croatian (hr)
Inventor
Baeckstroem Reijo
Granvik Paivi
Haikala Ritva
Pelttari Sirpa
Saukko Eva
Yrjoelae Reija
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8555263&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20020298(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of HRP20020298A2 publication Critical patent/HRP20020298A2/hr
Publication of HRP20020298B1 publication Critical patent/HRP20020298B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HR20020298A 1999-09-10 2000-09-08 Farmaceutske otopine levosimendana HRP20020298B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI991925A FI109659B (fi) 1999-09-10 1999-09-10 Levosimendaanin farmaseuttisia liuoksia
PCT/FI2000/000761 WO2001019334A2 (en) 1999-09-10 2000-09-08 Pharmaceutical solutions of levosimendan

Publications (2)

Publication Number Publication Date
HRP20020298A2 HRP20020298A2 (en) 2003-06-30
HRP20020298B1 true HRP20020298B1 (hr) 2007-02-28

Family

ID=8555263

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020298A HRP20020298B1 (hr) 1999-09-10 2000-09-08 Farmaceutske otopine levosimendana

Country Status (39)

Country Link
US (2) US6730673B1 (cs)
EP (1) EP1210085B1 (cs)
JP (1) JP4708648B2 (cs)
KR (1) KR100869752B1 (cs)
CN (1) CN1203855C (cs)
AR (1) AR025449A1 (cs)
AT (1) ATE315937T1 (cs)
AU (1) AU771027B2 (cs)
BG (1) BG65827B1 (cs)
BR (1) BRPI0013924B8 (cs)
CA (1) CA2382013C (cs)
CO (1) CO5180582A1 (cs)
CZ (1) CZ303095B6 (cs)
DE (1) DE60025627T2 (cs)
DK (1) DK1210085T3 (cs)
EA (1) EA005067B1 (cs)
EE (1) EE05375B1 (cs)
ES (1) ES2256034T3 (cs)
FI (1) FI109659B (cs)
HK (1) HK1049282B (cs)
HR (1) HRP20020298B1 (cs)
HU (1) HU228340B1 (cs)
IL (2) IL148379A0 (cs)
IS (1) IS2244B (cs)
ME (1) ME00523B (cs)
MX (1) MXPA02002423A (cs)
MY (1) MY125984A (cs)
NO (1) NO331989B1 (cs)
NZ (1) NZ517605A (cs)
PL (1) PL202356B1 (cs)
PT (1) PT1210085E (cs)
RS (1) RS50445B (cs)
SI (1) SI1210085T1 (cs)
SK (1) SK287154B6 (cs)
TR (1) TR200200620T2 (cs)
TW (1) TWI242434B (cs)
UA (1) UA73954C2 (cs)
WO (1) WO2001019334A2 (cs)
ZA (1) ZA200201828B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109659B (fi) * 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
CN100428937C (zh) * 2003-10-30 2008-10-29 北京海合天科技开发有限公司 左西孟旦冷冻干燥组合物
CN100367964C (zh) * 2004-04-29 2008-02-13 王思清 左西孟旦-β环糊精包含物制剂
US20070032557A1 (en) * 2005-02-18 2007-02-08 Matti Kivikko Method for administering levosimendan
JP2010514778A (ja) * 2006-12-28 2010-05-06 オリオン コーポレーション 非経口投与のためのレボシメンダン製剤
US10046081B2 (en) 2008-04-11 2018-08-14 The Henry M Jackson Foundation For The Advancement Of Military Medicine, Inc. Electrospun dextran fibers and devices formed therefrom
WO2012093404A2 (en) * 2011-01-03 2012-07-12 Gufic Biosciences Limited Parenteral formulations of levosimendan
US20130096479A1 (en) * 2011-10-18 2013-04-18 St. Teresa Medical, Inc. Method of forming hemostatic products
IN2014MN02271A (cs) * 2012-05-18 2015-07-24 Luoda Pharma Pty Ltd
CN105106113B (zh) * 2015-09-30 2019-07-26 济南康和医药科技有限公司 一种左西孟旦注射液及其制备方法
JP6770754B2 (ja) * 2015-11-06 2020-10-21 カリノファルム・ゲーエムベーハーＣａｒｉｎｏｐｈａｒｍ Ｇｍｂｈ 輸液又は注射として及び輸液濃縮物の静脈内投与のためのレボシメンダンの改善された調製物
AU2016351557A1 (en) 2015-11-12 2018-05-31 St. Teresa Medical, Inc. A method of sealing a durotomy
CN108261398A (zh) * 2016-12-30 2018-07-10 齐鲁制药有限公司 一种含有左西孟旦的供注射用药物制剂及其制备方法
WO2019089717A1 (en) 2017-11-02 2019-05-09 St. Teresa Medical, Inc. Fibrin sealant products
CN111474289A (zh) * 2019-10-31 2020-07-31 武汉嘉诺康医药技术有限公司 一种利用反相色谱分离分析左西孟旦中右西孟旦的方法
JP2023507626A (ja) 2019-12-16 2023-02-24 テナックス・セラピューティクス，インコーポレイテッド 駆出率が保たれた心不全を伴う肺高血圧症（ＰＨ－ＨＦ－ｐＥＦ）を治療するためのレボシメンダン
CN111514147B (zh) * 2020-05-12 2021-09-17 成都欣捷高新技术开发股份有限公司 用于急性失代偿心力衰竭症状的左西孟旦钠药用组合物及制备方法
US11760730B2 (en) * 2021-01-11 2023-09-19 Navinta, Llc Process for the preparation of high purity Levosimendan
WO2023027670A2 (en) * 2021-08-23 2023-03-02 Tum Ekip Ilac Anonim Sirketi Lyophilized levosimendan compositions
CN115518037A (zh) * 2022-10-14 2022-12-27 上药东英（江苏）药业有限公司 一种安全质量稳定的左西孟旦注射剂组合物及其制备方法
CN116473930B (zh) * 2023-05-17 2023-12-15 山东泰合医药科技有限公司 一种注射用左西孟旦及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2251615B (en) 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9606474D0 (en) 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI980902A7 (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaanin stabiileja koostumuksia
FI109659B (fi) * 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia

Also Published As

Publication number Publication date
DK1210085T3 (da) 2006-05-08
CO5180582A1 (es) 2002-07-30
CZ303095B6 (cs) 2012-03-28
SK287154B6 (sk) 2010-01-07
TR200200620T2 (tr) 2002-09-23
BR0013924A (pt) 2002-05-21
HUP0202749A2 (hu) 2003-02-28
EA200200348A1 (ru) 2002-08-29
HU228340B1 (en) 2013-03-28
FI19991925L (fi) 2001-03-10
ES2256034T3 (es) 2006-07-16
UA73954C2 (uk) 2005-10-17
KR20020048400A (ko) 2002-06-22
AR025449A1 (es) 2002-11-27
EE05375B1 (et) 2011-02-15
PL202356B1 (pl) 2009-06-30
YU16902A (sh) 2004-09-03
AU771027B2 (en) 2004-03-11
CN1203855C (zh) 2005-06-01
DE60025627D1 (de) 2006-04-06
EA005067B1 (ru) 2004-10-28
HK1049282B (zh) 2005-12-30
RS50445B (sr) 2010-03-02
ZA200201828B (en) 2003-08-27
US6943164B2 (en) 2005-09-13
NO20021090D0 (no) 2002-03-05
IL148379A (en) 2006-12-10
NO331989B1 (no) 2012-05-21
US6730673B1 (en) 2004-05-04
CZ2002788A3 (cs) 2002-11-13
BRPI0013924B8 (pt) 2021-05-25
CN1373665A (zh) 2002-10-09
PL354028A1 (pl) 2003-12-15
EP1210085A2 (en) 2002-06-05
JP2003509351A (ja) 2003-03-11
PT1210085E (pt) 2006-05-31
JP4708648B2 (ja) 2011-06-22
BG106589A (bg) 2002-11-29
BR0013924B1 (pt) 2013-09-24
MXPA02002423A (es) 2002-08-12
SK3272002A3 (en) 2002-12-03
KR100869752B1 (ko) 2008-11-21
NO20021090L (no) 2002-03-05
MY125984A (en) 2006-09-29
IS6296A (is) 2002-03-06
BG65827B1 (bg) 2010-02-26
AU7004400A (en) 2001-04-17
EE200200129A (et) 2003-04-15
FI109659B (fi) 2002-09-30
DE60025627T2 (de) 2006-11-16
NZ517605A (en) 2003-08-29
HRP20020298A2 (en) 2003-06-30
ME00523B (me) 2011-10-10
US20040106617A1 (en) 2004-06-03
ATE315937T1 (de) 2006-02-15
CA2382013C (en) 2009-08-11
TWI242434B (en) 2005-11-01
WO2001019334A3 (en) 2001-11-15
EP1210085B1 (en) 2006-01-18
HK1049282A1 (en) 2003-05-09
HUP0202749A3 (en) 2003-03-28
CA2382013A1 (en) 2001-03-22
IS2244B (is) 2007-05-15
SI1210085T1 (sl) 2006-04-30
IL148379A0 (en) 2002-09-12
WO2001019334A2 (en) 2001-03-22

Similar Documents

Publication Publication Date Title
HRP20020298B1 (hr) Farmaceutske otopine levosimendana
RS50360B (sr) Farmaceutske formulacije derivata platine
HRP20020198B1 (hr) Formulacija moksifloksacina i kuhinjske soli
MY129350A (en) Aripiprazole oral solution
TR200302105T4 (tr) Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
YU49354B (sh) Oralne tečne formulacije alendronata
ATE274344T1 (de) Pharmazeutische zubereitung mit verzögerter wirkstofffreisetzung von phenytoin natrium
PT921789E (pt) Suspensoes liquidas de sabor mascarado
NO20030533L (no) Vandige farmasöytiske preparater
YU6303A (sh) Nova heterociklična jedinjenja, njihovo dobijanje i njihova upotreba kao medikamenata, a naročito kao anti-bakterijskih agenasa
ATE323488T1 (de) Nitratsalze von antimikrobiellen wirkstoffen
GEP20053501B (en) Core Tablet for Controlled Release of Gliclazide after Oral Administration
EP0990648A4 (en) DERIVATIVES OF 4-CHINOLOL AND AGRICULTURAL AND GARDENING BACTERICIDES THAT CONTAIN THEM AS AN ACTIVE COMPONENT
MXPA03011480A (es) Una preparacion farmaceutica acuosa de cilostazol para uso parenteral.
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
YU59201A (sh) Matrica koja se može direktno komprimovati, za kontrolisano oslobadjanje pojedinačnih dnevnih doza klaritromicina
HRP20010878B1 (en) Ziprasidone suspension
RS50348B (sr) Farmaceutski oblik dronedarona za parenteralnu upotrebu
DK1957037T3 (da) Farmaceutisk præparat til nasal anvendelse af fentanyl
IT1250672B (it) Formulazioni orali di ubidecarenone in soluzione acquosa
BR9812982A (pt) Agente anti-reumático
HRP20020332B1 (hr) Oralne otopine koje sadrže galantamin i sladilo
ES2195819T3 (es) Formulaciones oftalmicas acuosas antibacterianas que contiene ofloxacino y chitosan.
EP1062948A4 (en) DRUGS AGAINST CARDIAC DIASTOLIC DISORDERS
NO940064L (no) Öyepreparat på polyakrylsyrebasis

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20190828

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20200908